Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

fdaoutsideweb

FDA new drug approvals sink to six year low

December 21, 2016 Medical Communications, Research and Development FDA, NDA, new drug approvals

The FDA has released figures to show that drug approvals have fallen from last year’s high of 45 new drugs …
News
allergan

Allergan shells out $2.9bn for regenerative medicine unit LifeCell

December 21, 2016 Research and Development, Sales and Marketing Allergan, LifeCell, acquisition

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …
News

Novartis seals two deals to bolster drug pipeline

December 21, 2016 Research and Development Conatus, Encore Vision, Novartis

Novartis has consolidated its ophthalmology position by acquiring Encore Vision, a Fort Worth-based US company. The company is focused on …
News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …
Appointment
640px-prostatic_adenocarcinoma_with_perineural_invasion

Treatment using light and deep-sea bacteria kills cancer cells

December 20, 2016 Medical Communications, Research and Development Vascular-targeted photodynamic therapy

A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …
News
ionis

Ionis achieves successful Phase 3 trial to treat rare diseases

December 19, 2016 Manufacturing and Production, Research and Development Akcea, Ionis, rare disease

Ionis Pharmaceutial announced that the results of a Phase 3 trial into its treatment for hypertriglyceridemia met its primary endpoint. …
News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016 Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …
News
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …
Appointment
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
Feature
fda2outsideweb

FDA orders new label warnings over anaesthetics risk in children

December 19, 2016 Research and Development, Sales and Marketing FDA, anaesthetics

The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …
News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …
Appointment
shutterstock_311949818

First human trial of tau-targeting Alzheimer’s vaccine shows promise

December 15, 2016 Medical Communications, Research and Development Alzheimer's

The latest in a succession of promising announcements surrounding Alzheimer’s R&D, researchers at the Karolinska Institutet in Stockholm, Sweden have …
News

Pfizer’s next blockbuster given FDA approval

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …
News
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …
News
justice_department

Former CEO and president of generics company charged with price fixing

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026